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The aim of the present study was to investigate the effects of daily
intragastric administration of bullfrog oil (oleic, linoleic and palmitoleic
acid-rich oil), corresponding to 0.4% of body weight for four weeks,
on fatty acid composition and oxidative stress (lipid peroxidation and
catalase activity) in mouse liver. The activities of aspartate ami-
notransferase (AST), alkaline phosphatase (ALP), alanine aminotrans-
ferase (ALT), and gamma-glutamyltransferase (GGT), biomarkers of
tissue injury, were determined in liver homogenates and serum. The
proportions of 18:2n-6, 20:4n-6, 20:5n-3, and 22:6n-3 (polyunsatu-
rated fatty acids, from 37 to 60%) in the total fatty acid content were
increased in the liver of the bullfrog oil-treated group (P < 0.05)
compared to control. At the same time, a significant decrease in the
relative abundance of 14:0, 16:0, and 18:0 (saturated fatty acids, from
49 to 25%) was observed. The hepatic content of thiobarbituric acid
reactive substances (TBARS) was increased from 2.3 ± 0.2 to 12.3 ±
0.3 nmol TBA-MDA/mg protein and catalase activity was increased
from 840 ± 32 to 1110 ± 45 µmol reduced H2O2 min-1 mg protein-1 in
the treated group. Bullfrog oil administration increased AST and ALP
activities in the liver (from 234.10 ± 0.12 to 342.84 ± 0.13 and 9.38 ±
0.60 to 20.06 ± 0.27 U/g, respectively) and in serum (from 95.41 ±
6.13 to 120.32 ± 3.15 and 234.75 ± 11.5 to 254.41 ± 2.73 U/l,
respectively), suggesting that this treatment induced tissue damage.
ALT activity was increased from 287.28 ± 0.29 to 315.98 ± 0.34 U/g
in the liver but remained unchanged in serum, whereas the GGT
activity was not affected by bullfrog oil treatment. Therefore, despite
the interesting modulation of fatty acids by bullfrog oil, a possible
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Several studies have shown the influence
of dietary fat on fatty acid (FA) composition
and oxidative stress in various tissues (1-8).
The proportion of FA in the diet is of great
physiological importance since it can modu-
late the composition of FA in cell membrane
phospholipids (1,2). This is due to the com-
petition among FA families for elongation
and desaturation enzymes. Some investiga-
tors have postulated that the unsaturated/
saturated FA (SFA) ratio of the diet is an
important factor for determining the intrin-
sic oxidative potential of tissues (3).
Oils of plant and animal origin have been
used for the treatment of immune and inflam-
matory disorders (2). These oils contain a
mixture of different types of SFA, monounsat-
urated FA (MUFA) and polyunsaturated FA
(PUFA). Bullfrog oil contains a relatively low
amount of SFA (17% of total FA) and PUFA
(28% of total FA) and is rich in MUFA (55%
of total FA). The sum of MUFA and PUFA
accounts for 83% of total FA in this oil and
makes it a candidate for therapeutic pur-
poses (2). However, there is no report on the
effects of bullfrog oil on animals.
In the present study, the effects of the
MUFA-rich bullfrog oil on FA composition
and oxidative stress (lipid peroxidation and
catalase activity) were investigated in mouse
liver. The liver and serum activities of aspar-
tate aminotransferase (AST), alanine ami-
notransferase (ALT), alkaline phosphatase
(ALP), and gamma-glutamyltransferase
(GGT) were also determined to assess the
occurrence of injury in the organ. Bullfrogs
can be easily grown to provide meat and
perhaps oil for therapeutic purposes.
Male Swiss mice (25-30 g) were divided
into two groups of 6 animals each fed Purina
commercial chow (5% fat), with free access
to water. The number of animals used in this
study was sufficient as indicated by the small
standard error of the means and by previous
work using the same methodology (5).
The animals received sterile saline solu-
tion (control group,) or bullfrog oil intragas-
trically daily for 4 weeks. The FA composi-
tion of bullfrog oil (%) is presented in Table
1. The amount of oil (0.4% of body weight)
administered as a supplement was recalcu-
lated daily on the basis of changes in body
weight assuming that the daily food intake of
a mouse is approximately 10% of body
weight, which corresponds to 0.4-0.5 g fat.
Therefore, the supplementation of oil at 0.4%
body weight increased by 2-fold the amount of
ingested fat. Bullfrog oil was given by gavage
to avoid the oxidation/peroxidation of FA
which occurs during the preparation of a fat-
rich diet. At the end of the study period, mice
were killed by decapitation and livers were
removed and stored at -80ºC.
For total lipid extraction, frozen samples
were homogenized in methanol and chloro-
form, followed by the addition of an aqueous
solution of KCl; after vortexing, the upper
layer phase was discarded. The FA were
saponified with an alcoholic solution of
NaOH and then extracted twice with HCl
and hexane as described elsewhere (9). FA
were derivatized with 4-bromomethyl-7-cou-
marin and the composition was analyzed by
high performance liquid chromatography
(Shimadzu model LC-10A, Kyoto, Japan)
using a C8 column with a C8 pre-column,
eluted with 1 ml/min acetonitrile/water
(77:23, by volume) and the effluent was
monitored with a fluorescence detector (325-
nm excitation and 395-nm emission) (9). FA
used as standards were obtained from Sigma
(St. Louis, MO, USA). Intra- and interassay
coefficients of variation (CV) were less than
8%. FA composition is presented in Table 1
as percent of the total identified FA.
The unsaturation indexes of the FA pres-
ent in bullfrog oil and liver were calculated
as described in Ref. 10. The percentage of
each FA was multiplied by the number of
double bonds present. The sum was calcu-
lated and the values are presented in Table 1.
For the determination of thiobarbituric
acid reactive substances (TBARS), frozen
liver samples were homogenized in phos-
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phate buffer containing butylated hydroxy-
toluene and 2-thiobarbituric acid. After in-
cubation at 100ºC for 30 min, the mixture
was cooled and the TBARS adducts were
extracted with butanol and centrifuged at
1600 g at 4°C for 30 min. The supernatant
phase (butanol phase) was collected and ab-
sorbance at 532 nm was measured with a
Pharmacia Biotech Ultrospec 3000 Spectro-
photometer (Uppsala, Sweden) (11). TBARS
are reported as µmol/mg protein using a
molar absorptivity of 1.56 x 10-5 M-1 ml-1.
For the determination of hepatic catalase
activity, samples were homogenized in phos-
phate buffer and centrifuged, and the super-
natant was used for analysis. Catalase activ-
ity was determined in duplicate by monitor-
ing the decomposition of H2O2 at 30ºC with
a UV visible spectrophotometer at 230 nm
(12). Catalase specific activity is reported as
µmol reduced H2O2 min-1 mg protein-1. The
protein content of the liver homogenates was
measured by the method of Bradford (13).
ALT, AST, ALP, and GGT activities were
determined in serum and liver using a Bayer
ADVIA 1650 clinical chemistry analyzer
(Lerverkusen, Germany) according to manu-
facturer instructions. The liver was homog-
enized in 0.2 g/ml phosphate-buffered sa-
line, pH 7.4. Blood samples were collected
into test tubes and allowed to stand for 30
min to clot before centrifugation at 300 g for
10 min. The serum was separated, trans-
ferred to other tube, and stored at 4ºC for
subsequent analysis.
All data are reported as means ± SEM. The
results were submitted to one-way ANOVA,
and means were compared between groups by
Scheffé’s test. Results were considered statis-
tically significant when P < 0.05.
The dose of bullfrog oil administered did
not cause diarrhea or any other visible clini-
cal symptoms in the animals. Mice of both
groups were healthy and had similar final
body weights (27.2 ± 0.6 for controls and
26.3 ± 0.3 g for bullfrog oil-treated animals).
Liver FA composition was changed by
bullfrog oil administration (Table 1). The
proportion of SFA was decreased by 48%,
with a significant reduction in the relative
abundance of 14:0 (63%), 16:0 (44%), and
18:0 (54%; P < 0.05). Conversely, the pro-
portion of PUFA was increased 62% (P <
0.05) and the PUFA/SFA ratio was increased
213% (P < 0.05). The most altered PUFA
class was n-3 PUFA, which increased 143%
(P < 0.05). The significant (P < 0.05) in-
crease of n-6 PUFA was much smaller (34%).
The n-3 PUFA/n-6 PUFA ratio was also
increased 81% (P < 0.05). Among the n-3
Table 1. Fatty acid composition of bullfrog oil and of the liver of bullfrog oil-treated
mice.
Fatty acids (%) Bullfrog oil Liver
Control group Bullfrog oil-treated
group
12:0 0.21 0.50 ± 0.02 0.59 ± 0.03
14:0 2.77 1.76 ± 0.06 0.65 ± 0.02*
16:0 11.91 27.90 ± 1.15 15.58 ± 0.72*
16:1 (n-9) 17.31 2.45 ± 0.09 3.03 ± 0.08
18:0 2.34 18.35 ± 0.65 8.51 ± 0.40*
18:1 (n-9) 37.60 12.38 ± 0.43 11.93 ± 0.54
18:2 (n-6) 23.78 14.46 ± 0.78 20.50 ± 0.93*
18:3 (n-3) 1.97 0.53 ± 0.01 0.21 ± 0.02*
20:4 (n-6) 0.74 11.95 ± 0.77 15.37 ± 0.54*
20:5 (n-3) 0.46 0.83 ± 0.03 1.11 ± 0.05*
22:6 (n-3) 0.91 8.89 ± 0.31 22.52 ± 0.95*
SFA 17.23 48.51 ± 2.43 25.33 ± 1.21*
UFA 82.77 51.49 ± 2.93 74.67 ± 2.89*
MUFA (n-9) 54.91 14.83 ± 0.81 14.96 ± 0.84
PUFA 27.86 36.66 ± 1.78 59.71 ± 2.11*
n-3 PUFA 1.37 9.72 ± 0.32 23.63 ± 1.12*
n-6 PUFA 26.49 26.94 ± 1.29 36.08 ± 1.77*
n-3 PUFA/n-6 PUFA 0.05 0.36 ± 0.02 0.65 ± 0.04*
PUFA/SFA 1.62 0.75 ± 0.03 2.35 ± 0.15*
PUFA:MUFA:SFA 1.62:3.19:1.00 0.75:0.31:1.00 2.35:0.59:1.00*
Unsaturation index 119.10 150.63 258.74
Triacylglycerol+ 84.25 -
Monoacylglycerol+ 10.31 - -
Cholesterol+ 4.31 - -
Free fatty acids+ 1.13 - -
Mice (25-30 g) received the oil (0.4% of body weight) by gavage daily for 4 weeks.
Data are reported as the mean ± SEM of percent recovered fatty acids by weight for
three determinations in each of the 6 mice in each group. SFA = sum of saturated
fatty acids (FA); UFA = sum of unsaturated FA; MUFA = sum of monounsaturated FA;
PUFA: sum of polyunsaturated FA; n-3 PUFA = sum of n-3 PUFA; n-6 PUFA = sum of
n-6 PUFA. +Lipid class composition (%).
*P < 0.05 compared to control (one-way ANOVA and Scheffé’s test).
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PUFA, the liver of bullfrog oil-treated ani-
mals had a higher proportion (P < 0.05) of
22:6n-3 (153%) and 20:5n-3 (34%) and a
decreased proportion of 18:3n-3 (60%). A
29 and 42% increase of 20:4n-6 and 18:2n-6
was observed in n-6 PUFA, respectively (P <
0.05). No significant differences were observed
in the proportion of MUFA between groups.
TBARS content (Table 2) in the liver of
bullfrog oil-treated animals changed from
2.3 ± 0.2 to 12.3 ± 0.3 nmol TBA-MDA
formed per mg protein (435%). Catalase ac-
tivity (Table 2) was increased by bullfrog oil
administration from 840 ± 32 to 1110 ± 45
µmol reduced H2O2 min-1 mg protein-1 (32%).
AST, ALT, and ALP activities were in-
creased by 46, 10, and 114%, respectively, in
the liver of bullfrog oil-treated animals com-
pared to the control (P < 0.05). There was a
statistically significant 26 and 8% increase in
AST and ALP activities, respectively, in the
serum of bullfrog oil-treated mice (Table 2),
but no significant effect on ALT activity in
serum, or on GGT activity in liver and serum
(Table 2).
As previously mentioned, bullfrog oil is a
MUFA-rich animal-derived oil. MUFA (n-9
and n-7) account for 55% of total FA, con-
sisting of 38% oleic acid (18:1n-9) and 17%
palmitoleic acid (16:1n-7). Linoleic acid
(18:2n-6) was the second most abundant FA
(24%) and accounted for almost 100% of n-
6 FA in bullfrog oil. Bullfrog oil was poor in
linolenic acid (18:3n-3) and in FA contain-
ing 20 or more carbons (Table 1). Although
bullfrog oil is similar to canola oil in terms of
total PUFA and MUFA, the former contains
almost 100% more oleic acid and 350%
more linolenic acid (ALA), as well as about
200% less total SFA than the latter.
The influence of dietary lipids on liver FA
composition has been demonstrated in exper-
imental animal studies using different oils
(1,14,15). In the present study, intragastric
administration of bullfrog oil caused an in-
crease in long-chain PUFA (20:4n-6, 20:5n-3,
and 22:6n-3) and a decrease in SFA (14:0,
16:0, and 18:0) in the liver. Bullfrog oil led to
an increase in total liver PUFA, n-3 PUFA,
and n-6 PUFA, concomitant with a decrease in
total SFA. Total MUFA content did not differ
between groups, although bullfrog oil-treated
liver had a higher relative content of these FA.
Arachidonic acid (AA), eicosapentaenoic
acid (EPA), and docosahexaenoic acid
(DHA) are PUFA obtained from the diet or
Table 2. Effect of intragastric bullfrog oil administration on TBARS, catalase, alkaline phosphatase, and
aminotransferase activities of mouse liver and serum. Bullfrog oil administration is described in the legend to
Table 1.
Liver  Serum
Control Bullfrog oil-treated Control Bullfrog oil-treated
group group group group
TBARS (nmol/mg protein) 2.3 ± 0.2 12.3 ± 0.3* - -
Catalase (µmol min-1 mg protein-1) 840 ± 32 1110 ± 45* - -
AST (U/g in liver and U/l in serum) 234.10 ± 0.12 342.84 ± 0.13* 95.41 ± 6.13 120.32 ± 3.15*
ALP (U/g in liver and U/l in serum) 9.38 ± 0.60 20.06 ± 0.27* 234.75 ± 11.50 254.41 ± 2.73*
ALT (U/g in liver and U/l in serum) 287.28 ± 0.29 315.98 ± 0.34* 74.00 ± 10.58 71.98 ± 4.25
GGT (U/g in liver and U/l in serum) 0.22 ± 0.03 0.16 ± 0.09 24.52 ± 3.71 20.25 ± 1.50
Data are reported as the mean ± SEM of three determinations in each of the 6 mice in each group. AST =
aspartate aminotransferase; ALT = alanine aminotransferase; ALP = alkaline phosphatase; GGT = gamma-
glutamyltransferase; TBARS = thiobarbituric acid reactive substances. One unit of the aminotransferases
and ALP is defined as the amount of enzyme required to produce 1 µmol of NAD or p-nitrophenol,
respectively, per minute under the conditions of the assay.
*P < 0.05 compared to control (one-way ANOVA and Scheffé’s test).
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synthesized from their direct precursors,
linoleic acid for AA and ALA for EPA and
DHA, in a process involving elongase/de-
saturase enzymes. Therefore, the relative in-
crease of AA in the liver of bullfrog oil-
treated animals may be explained by direct
incorporation and/or by formation from its
precursor, since it is present in relatively
high amounts in bullfrog oil compared to
other oils. Similarly, the increase in EPA and
DHA may be explained by direct incorpora-
tion and/or synthesis from ALA present in
bullfrog oil. An increase in the proportions
of total n-3 PUFA in brain and liver (includ-
ing EPA and DHA) has been observed in a
number of studies involving feeding of olive
oil, which contains a low proportion of n-3
PUFA and its precursors (15,16). Interest-
ingly, in the present study the incorporation
of n-9 FA was very low. Weber et al. (17),
studying the metabolism of mead acid (20:3n-
9), observed an accumulation of n-3 and n-6
products such as DHA, EPA, and AA, as
also observed in the present study. These
investigators proposed that a feedback mech-
anism might down-regulate the n-9 pathway
in the liver, preventing further conversion of
dietary precursors and/or direct incorpora-
tion. In this case, n-9 FA catabolism might
be stimulated. Sprecher et al. (18) studying
n-6 FA, also suggested an inverse relation-
ship between rates of peroxisomal ß-oxida-
tion and FA esterification.
Increased catabolism via peroxisomal ß-
oxidation leads to an in vivo increase of
hydrogen peroxide production that is poten-
tially toxic to the cell. Catalase is predomi-
nantly found in the peroxisomes of most
cells and converts hydrogen peroxide to oxy-
gen and water, preventing oxidative stress
and playing an antioxidant defense role (19).
Supporting the postulated increase in per-
oxisomal ß-oxidation in bullfrog oil-treated
animals, there was an increase in liver cata-
lase activity. The increase in the activity of
this enzyme is perhaps an attempt to protect
against hydrogen peroxide toxicity.
An increase in the proportion of PUFA in
the membranes and of the unsaturation in-
dex was directly associated with the eleva-
tion of membrane lipid peroxidation. Lipid
peroxidation is a highly destructive phenom-
enon that propagates free radicals and leads
to the release of a wide variety of relatively
stable breakdown products known to be toxic.
Our study showed an elevated TBARS con-
tent in the liver of bullfrog oil-treated ani-
mals, which was associated with the increase
in the PUFA/SFA ratio (Table 1). These
results agree with previous studies indicat-
ing that a high PUFA/SFA ratio in the diet is
partially responsible for the increase of
TBARS content leading to histological and
functional damage in the liver (20).
AST, ALT, GGT, and ALP activities serve
as biomarkers of liver injury (20). It is gener-
ally assumed that an increase of these en-
zyme activities reflects active inflammation
and necrosis of hepatic cells, whereas a de-
crease indicates a decline of hepatic inflam-
mation and may lead to morphological im-
provement (20). Our results indicate that the
increase in lipid peroxidation in the liver of
bullfrog oil-treated animals promoted dam-
age to liver cells, which led to an increase of
AST, ALT, and ALP activities in the liver.
However, in spite of this, an increase (P <
0.05) of the AST and ALP activities, but not
of ALT, was observed in blood serum. These
results suggest that bullfrog oil supplemen-
tation can promote damage to the liver. This
small change, however, did not lead to mor-
phological changes or leukocyte infiltration,
as observed by light microscopy of the liver
(data not shown).
Intragastric treatment of mice with bull-
frog oil promotes elevation of the relative
amount of PUFA (such as AA, EPA, and
DHA) and a decrease in SFA (14:0, 16:0,
and 18:0) in the liver. Bullfrog oil supple-
mentation also led to an increase of TBARS
content in the liver and of AST and ALP
activities in serum, suggesting that this treat-
ment induces tissue damage.
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